# A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid

> clinical trial · VERIFIED · 2026-06-18

Status: COMPLETED · Sponsor: Regeneron Pharmaceuticals · Condition: Bullous Pemphigoid

- Company: Regeneron Pharmaceuticals
- Sector: immunology
- Primary source: https://clinicaltrials.gov/study/NCT04206553

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.